Atlas Trials

Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy

Clinical trial NCT02367014 · COMPLETED

Trial details

NCT number
NCT02367014
Sponsor
Stealth BioTherapeutics Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mitochondrial Myopathy
Start date
2015-02-01
Primary completion
2016-04-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.